Quantification of Degree of Steatosis in Extended Criteria Donor Grafts With Standardized Histologic Techniques: Implications for Graft Survival

Transplantation Proceedings

Volumn 41, Issue 4, 2009, Pages 1268-1272

  Frongillo, F ^a   Avolio, A W ^a   Nure, E ^a   Mule A ^b   Pepe, G ^a   Magalini, S C ^a   Agnes, S ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; FATTY ACID; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER DISEASE; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR; DONOR; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; FATTY LIVER; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MIDDLE AGED; TISSUE DONORS;

EID: 65549164185     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.096     Document Type: Article

References (27)

1. Cameron A.M., Ghobrial R.M., Yersiz H., et al. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg 243 (2006) 748
2. Starzl T.E. Back to the future. Transplantation 79 (2005) 1009
3. Schemmer P., Nickkholgh A., Hinz U., et al. Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis. Transplant Proc 39 (2007) 529
4. Nickkholgh A., Weitz J.E., Sauer P., et al. Utilization of extended donor criteria in liver transplantation: a comprehensive review of the literature. Nephrol Dial Transplant 22 suppl 8 (2007) viii29
5. Farell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99
6. Preiss D., and Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenes and treatment considerations. Clin Sci (Lond) 115 (2008) 141
7. Ploeg R.J., D'Alessandro A.M., Knechtle S.J., et al. Risk factors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation 55 (1993) 807
8. Sallizoni M., Franchello A., Zamboni F., et al. Marginal grafts: finding the correct treatment for fatty livers. Transpl Int 16 (2003) 486
9. Angelico M. Donor liver steatosis and graft selection for liver transplantation: a short review. Eur Rev Med Pharmacol Sci 9 (2005) 295
10. Frankel W.L., Tranovich J.G., Salter L., et al. The optimal number of donor biopsy sites to evacuate liver histopatology for transplantation. Liver Transplant 8 (2002) 1044
11. Jo I.L., Lefkowitch J.H., Feirt N., et al. Utility of liver allograft biopsy obtained at procurement. Liver Transplant 14 (2008) 639
12. Urena M.A.G., Ruiz-Delgado F.C., Gonzalez E.M., et al. Hepatic steatosis in liver transplant donors: common feature of donor population?. World J Surg 22 (1998) 837
13. Angele M.K., Rentsch M., Hartl W.H., et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg 195 (2008) 214
14. Wong VS, Dwight DG, Palmer CR, et al: Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model. J Clin Pathol 49:465, 996
15. Verran D., Kusyk T., Painter D., et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transplant 9 (2003) 500
16. Adam R., Reynes M., Johann M., et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc 23 (1991) 1538
17. Zamboni F., Franchello A., David E., et al. Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation. Clin Transplant 15 (2001) 53
18. Avolio A.W., Agnes S., Chirico A.S.A., et al. Primary dysfunction after liver transplantation: donor or recipient fault?. Transplant Proc 31 (1999) 434
19. Busuttil R.W., and Tanaka K. The utility of marginal donors in liver transplantation. Liver Transplant 9 (2003) 651
20. D'Alessandro A.M., Kalayoglu M., Sollinger H.W., et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation 51 (1991) 157
21. Kim K.W., Kim M.J., Lee S.S., et al. Sparing of fatty infiltration around focal hepatic lesions in patients with hepatic steatosis: sonographic appearance with CT and MRI correlation. AJR 190 (2008) 1018
22. Fishbein T.M., Fiel M.I., Emre S., et al. Use of livers with microvescicular fat safely expands the donor pool. Trasplantation 64 (1997) 248
23. McCormack L., Petrowsky H., Jochum W., et al. Use of severely steatotic grafts in liver transplantation: a matched case-control study. An Surg 246 (2007) 940
24. Loinaz Gonzalez E.M. Marginal donors in liver transplantation. Hepatogastroenterology 47 (2000) 256
25. Adam R., Cailliez V., Majno P., et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study [published correction appears in Lancet 21;367, 2000]. Lancet 356 (2000) 621
26. Renza J.F., Kin C., Kinkhabwala M., et al. utilization of extended criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 242 (2005) 556
27. Kamath P.S., Wiesner R.H., Malinchoc M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464